Pfizer's vaccine candidate showing promise after research done in Maryland

As coronavirus cases continue to rise across the country, one vaccine candidate is showing signs of promise. Drug company Pfizer revealed Monday its trial coronavirus vaccine is more than 90% effective at preventing infection with few safety concerns. The promising vaccine got its start at the University of Maryland School of Medicine, which ran phase one of the clinical trial.